Status:
UNKNOWN
Eye Drops Study for Myopia Control in Schoolchildren
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Myopia, Progressive
Atropine Allergy
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
The myopia prevalence in schoolchildren is high in Taiwan. The myopia progression is fast in children and often associated high myopia in later life. This prospective and randomized study to investiga...
Detailed Description
Myopia onset earlier in children who would suffer a high degree of myopia in the future adulthood.and higher risk for retinal detachment, macular degeneration, and even blindness. In Taiwan, myopia ma...
Eligibility Criteria
Inclusion
- Myopia diagnosed with the spherical equivalent refraction at least -0.5 diopter (D)
- Must be able to use eye drops
Exclusion
- astigmatism -1.50 D or greater
- strabismus
- amblyopia
- cataract
- glaucoma
- any ocular diseases ocular surgery
- history of systemic diseases (ex. asthma, heart disease...)
- contact lenses user
- orthokeratology user
Key Trial Info
Start Date :
October 20 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03402100
Start Date
October 20 2014
End Date
December 31 2019
Last Update
January 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 833